Daily Forecast
The Forecast
2023.07.04
The US dollar shows ambiguous results against currency majors. Investors continue to monitor the progress of the new stimulus package for the US economy. ECB officials are concerned about the prospect...
Read more
The Forecast
2023.07.04
The FOMC meeting minutes were published yesterday. Officials expect the Fed to continue assets purchases "at least at the current pace" in the coming months.
Read more
The Forecast
2023.07.04
The greenback shows ambiguous results against its main competitors. Financial market participants assess the previous debate between Donald Trump and his challenger Joe Biden.
Read more
The Forecast
2023.07.04
Yesterday, Donald Trump ordered to end negotiations in the US Congress on a new stimulus package. These events caused a sharp drop in demand for "risky" assets. Today, investors will be focused on the...
Read more
The Forecast
2023.07.04
Currency majors are being traded stable. Investors expect a debate between Donald Trump and Joe Biden and updates on a new stimulus package in the US and negotiations on Brexit. Positions should be op...
Read more
The Forecast
2023.07.04
Today, British Prime Minister Boris Johnson will decide whether or not to postpone the final stage of lockdown lifting scheduled for later this month.
Read more
The Forecast
2023.07.04
Currency majors show a variety of trends. The publication of important economic releases is not planned today.
Read more
The Forecast
2023.07.04
On Thursday, the dollar index declined in light of Jerome Powell’s comments and labor market data. The head of the Fed says that the monetary regulator has tools to combat high inflation, and they wil...
Read more
The Forecast
2023.07.04
Currency pairs move in different directions. Investors have taken a wait-and-see attitude before the Fed meeting. Financial market participants are afraid that the deal between the EU and the UK will...
Read more
The Forecast
2023.07.04
The US dollar has declined against a basket of currency majors amid growing interest for risk. As it became known, AstraZeneca has resumed the latest trials of the COVID-19 vaccine. Today, investors e...
Read more